[
  {
    "ts": "2026-02-03T00:00:00+00:00",
    "headline": "AMD earnings, Netflix-Warner Bros. hearing: What to Watch",
    "summary": "Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Tuesday, February 3, including earnings results from companies like Advanced Micro Devices (AMD), Chipotle Mexican Grill (CMG), Pfizer (PFE), and Merck (MRK), and the Senate hearing on Netflix's (NFLX) proposed bid to acquire Warner Bros. Discovery (WBD). To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Domination Overtime.",
    "url": "https://finance.yahoo.com/video/amd-earnings-netflix-warner-bros-000000934.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "944ac714-6d5e-3cf9-ac3d-5262ebfd6519",
      "content": {
        "id": "944ac714-6d5e-3cf9-ac3d-5262ebfd6519",
        "contentType": "VIDEO",
        "title": "AMD earnings, Netflix-Warner Bros. hearing: What to Watch",
        "description": "<p>Market Domination Overtime Host <a data-i13n=\"cpos:1;pos:1\" href=\"https://www.yahoo.com/author/josh-lipton/\">Josh Lipton</a> previews several of the biggest stories to come tomorrow, Tuesday, February 3, including earnings results from companies like Advanced Micro Devices (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/AMD\">AMD</a>), Chipotle Mexican Grill (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/CMG\">CMG</a>), Pfizer (<a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/PFE\">PFE</a>), and Merck (<a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/quote/MRK\">MRK</a>), and the Senate hearing on Netflix's (<a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/quote/NFLX\">NFLX</a>) proposed bid to acquire Warner Bros. Discovery (<a data-i13n=\"cpos:7;pos:1\" href=\"https://finance.yahoo.com/quote/WBD\">WBD</a>).</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:8;pos:1\" href=\"https://finance.yahoo.com/videos/series/market-domination-overtime/\">Market Domination Overtime</a>.</p>",
        "summary": "Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Tuesday, February 3, including earnings results from companies like Advanced Micro Devices (AMD), Chipotle Mexican Grill (CMG), Pfizer (PFE), and Merck (MRK), and the Senate hearing on Netflix's (NFLX) proposed bid to acquire Warner Bros. Discovery (WBD). To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Domination Overtime.",
        "pubDate": "2026-02-03T00:00:00Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-02/67792e30-0073-11f1-bfff-3c4891fc6d0b",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UzqQCDUXj0MPW_tlpZ7E0A--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-02/67792e30-0073-11f1-bfff-3c4891fc6d0b.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/n0CeAGm.cJ44Rdq8zCs3Mw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-02/67792e30-0073-11f1-bfff-3c4891fc6d0b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/amd-earnings-netflix-warner-bros-000000934.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/amd-earnings-netflix-warner-bros-000000934.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NFLX"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "PYPL"
            },
            {
              "symbol": "CMG"
            },
            {
              "symbol": "WBD"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T03:14:36+00:00",
    "headline": "Assessing Amgen (AMGN) Valuation After Ending Kyowa Kirin Rocatinlimab Collaboration",
    "summary": "Amgen (AMGN) has just walked away from its licensing and collaboration agreement with Kyowa Kirin on rocatinlimab for atopic dermatitis, a portfolio reshuffle that shifts responsibility back to Kyowa Kirin and repositions Amgen’s near term pipeline focus. See our latest analysis for Amgen. Those portfolio moves sit alongside a share price that has climbed to US$344.68, with a 30 day share price return of 5.2% and a 1 year total shareholder return of 23.14%, which suggests that momentum has...",
    "url": "https://finance.yahoo.com/news/assessing-amgen-amgn-valuation-ending-031436152.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "366cb14c-8d29-3a75-b321-72cb70abcf98",
      "content": {
        "id": "366cb14c-8d29-3a75-b321-72cb70abcf98",
        "contentType": "STORY",
        "title": "Assessing Amgen (AMGN) Valuation After Ending Kyowa Kirin Rocatinlimab Collaboration",
        "description": "",
        "summary": "Amgen (AMGN) has just walked away from its licensing and collaboration agreement with Kyowa Kirin on rocatinlimab for atopic dermatitis, a portfolio reshuffle that shifts responsibility back to Kyowa Kirin and repositions Amgen’s near term pipeline focus. See our latest analysis for Amgen. Those portfolio moves sit alongside a share price that has climbed to US$344.68, with a 30 day share price return of 5.2% and a 1 year total shareholder return of 23.14%, which suggests that momentum has...",
        "pubDate": "2026-02-03T03:14:36Z",
        "displayTime": "2026-02-03T03:14:36Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ACuIXYrNeojUXbAJFhnPIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/B7CQJIEa.2c0sQ0XIU66pg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/assessing-amgen-amgn-valuation-ending-031436152.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/assessing-amgen-amgn-valuation-ending-031436152.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "KYKOF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T12:24:06+00:00",
    "headline": "Jim Cramer on Amgen: “The Biotech Really Impressed Me With a Very Strong Pipeline”",
    "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the stocks on Jim Cramer’s recent game plan. Cramer said that he heard good things about the company during the JPMorgan Healthcare Conference, as he commented: With Amgen, I don’t know if you remember, at the JPMorgan Healthcare Conference, I heard a lot of good things. The biotech really […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-amgen-biotech-really-122406856.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "9e113368-7116-3838-a81d-867e64833c7c",
      "content": {
        "id": "9e113368-7116-3838-a81d-867e64833c7c",
        "contentType": "STORY",
        "title": "Jim Cramer on Amgen: “The Biotech Really Impressed Me With a Very Strong Pipeline”",
        "description": "",
        "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the stocks on Jim Cramer’s recent game plan. Cramer said that he heard good things about the company during the JPMorgan Healthcare Conference, as he commented: With Amgen, I don’t know if you remember, at the JPMorgan Healthcare Conference, I heard a lot of good things. The biotech really […]",
        "pubDate": "2026-02-03T12:24:06Z",
        "displayTime": "2026-02-03T12:24:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/753cb9cb32336de8f86289f7a7c7b36e",
          "originalWidth": 6144,
          "originalHeight": 3456,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yUwpYgqiuVEAjPqpC4y7Ww--~B/aD0zNDU2O3c9NjE0NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/753cb9cb32336de8f86289f7a7c7b36e.cf.webp",
              "width": 6144,
              "height": 3456,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Q.HNxvelm8rTEuW9n.Ys6Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/753cb9cb32336de8f86289f7a7c7b36e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-amgen-biotech-really-122406856.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-amgen-biotech-really-122406856.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T12:16:17+00:00",
    "headline": "Stocks Mostly Rise Pre-Bell as Investors Await Latest Round of Corporate Earnings",
    "summary": "US equity futures were mostly pointing higher on Tuesday as traders await a fresh batch of corporate",
    "url": "https://finance.yahoo.com/news/stocks-mostly-rise-pre-bell-121617545.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "36c8c3ff-12fb-31be-8c10-4a8d88132e3c",
      "content": {
        "id": "36c8c3ff-12fb-31be-8c10-4a8d88132e3c",
        "contentType": "STORY",
        "title": "Stocks Mostly Rise Pre-Bell as Investors Await Latest Round of Corporate Earnings",
        "description": "",
        "summary": "US equity futures were mostly pointing higher on Tuesday as traders await a fresh batch of corporate",
        "pubDate": "2026-02-03T12:16:17Z",
        "displayTime": "2026-02-03T12:16:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/8685121785649cec3dbcdbbd25333a86",
          "originalWidth": 1024,
          "originalHeight": 683,
          "caption": "wall street stock market flag new york trading equity - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QVMgErJdOR7IkzCjRHm3pQ--~B/aD02ODM7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/8685121785649cec3dbcdbbd25333a86.cf.webp",
              "width": 1024,
              "height": 683,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dimQxOClk1isv1IKNf9JtA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/8685121785649cec3dbcdbbd25333a86.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/stocks-mostly-rise-pre-bell-121617545.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stocks-mostly-rise-pre-bell-121617545.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TER"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "NXPI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "ITW"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "MDLZ"
            },
            {
              "symbol": "CMG"
            },
            {
              "symbol": "EA"
            },
            {
              "symbol": "TDG"
            },
            {
              "symbol": "PYPL"
            },
            {
              "symbol": "ADM"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "EMR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T11:26:22+00:00",
    "headline": "Nasdaq Futures Climb on Blowout Palantir Results",
    "summary": "March Nasdaq 100 E-Mini futures (NQH26) are trending up +0.41% this morning as forecast-beating quarterly results and guidance from Palantir Technologies boosted sentiment.",
    "url": "https://www.barchart.com/story/news/37377340/nasdaq-futures-climb-on-blowout-palantir-results",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "a13bd3a0-c685-3674-9604-35354efa5f0b",
      "content": {
        "id": "a13bd3a0-c685-3674-9604-35354efa5f0b",
        "contentType": "STORY",
        "title": "Nasdaq Futures Climb on Blowout Palantir Results",
        "description": "",
        "summary": "March Nasdaq 100 E-Mini futures (NQH26) are trending up +0.41% this morning as forecast-beating quarterly results and guidance from Palantir Technologies boosted sentiment.",
        "pubDate": "2026-02-03T11:26:22Z",
        "displayTime": "2026-02-03T11:26:22Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/9a1ff5003151ccd77c6a21a4e3c76ded",
          "originalWidth": 1600,
          "originalHeight": 1068,
          "caption": "Nasdaq Times Square by Lucky Photographer via iStock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1TEunvsuvYg5NCUJL7Pj0g--~B/aD0xMDY4O3c9MTYwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/barchart_com_477/9a1ff5003151ccd77c6a21a4e3c76ded.cf.webp",
              "width": 1600,
              "height": 1068,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gAXtlTbrflDl0BGZshHWaQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/9a1ff5003151ccd77c6a21a4e3c76ded.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/37377340/nasdaq-futures-climb-on-blowout-palantir-results",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nasdaq-futures-climb-blowout-palantir-112622644.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NQH26"
            },
            {
              "symbol": "TER"
            },
            {
              "symbol": "DIS"
            },
            {
              "symbol": "INTC"
            },
            {
              "symbol": "PEP"
            },
            {
              "symbol": "MU"
            },
            {
              "symbol": "RMBS"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "AMUN.P.DX"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "GC=F"
            },
            {
              "symbol": "SNDK"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T18:27:28+00:00",
    "headline": "Obesity stocks slump on Novo's underwhelming 2026 sales forecast",
    "summary": "Feb 3 (Reuters) - Shares of obesity drugmakers and developers slid on Tuesday after Novo Nordisk forecast a sharper-than-expected sales decline for 2026, underscoring intensifying competition in the",
    "url": "https://ca.finance.yahoo.com/news/obesity-stocks-slump-novos-underwhelming-182728439.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "3b7b0f91-d0a3-3f96-8fa5-abf29677ceaa",
      "content": {
        "id": "3b7b0f91-d0a3-3f96-8fa5-abf29677ceaa",
        "contentType": "STORY",
        "title": "Obesity stocks slump on Novo's underwhelming 2026 sales forecast",
        "description": "",
        "summary": "Feb 3 (Reuters) - Shares of obesity drugmakers and developers slid on Tuesday after Novo Nordisk forecast a sharper-than-expected sales decline for 2026, underscoring intensifying competition in the",
        "pubDate": "2026-02-03T18:27:28Z",
        "displayTime": "2026-02-03T18:27:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/ed0f16ee519c89d890321f14cbb468f8",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "FILE PHOTO: A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by Novo Nordisk. REUTERS/Hollie Adams/Brendan McDermid/Combination/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dNztZcR2q0tet4W_8rBY4A--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/ed0f16ee519c89d890321f14cbb468f8.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Sz3cScsHUSaL4rHQnnECuw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/ed0f16ee519c89d890321f14cbb468f8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://ca.finance.yahoo.com/news/obesity-stocks-slump-novos-underwhelming-182728439.html",
          "site": "finance",
          "region": "CA",
          "lang": "en-CA"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/obesity-stocks-slump-novos-underwhelming-182728439.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "VKTX"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "GPCR"
            },
            {
              "symbol": "ALT"
            }
          ],
          "premiumFinance": null
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T19:00:48+00:00",
    "headline": "Equities Fall Intraday as Tech Sector Slumps; Precious Metals Jump",
    "summary": "US benchmark equity indexes were lower intraday amid a plunge in the technology sector, while gold a",
    "url": "https://finance.yahoo.com/news/equities-fall-intraday-tech-sector-190048469.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "0e50bfa2-3c6b-3996-9c5e-5468df41497a",
      "content": {
        "id": "0e50bfa2-3c6b-3996-9c5e-5468df41497a",
        "contentType": "STORY",
        "title": "Equities Fall Intraday as Tech Sector Slumps; Precious Metals Jump",
        "description": "",
        "summary": "US benchmark equity indexes were lower intraday amid a plunge in the technology sector, while gold a",
        "pubDate": "2026-02-03T19:00:48Z",
        "displayTime": "2026-02-03T19:00:48Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/0c887a492733aab96ac405a5871f559a",
          "originalWidth": 1024,
          "originalHeight": 768,
          "caption": "Stocks_Chart market equity trading wall street - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0eWqzzTTIs4ZCQG0VOzLjA--~B/aD03Njg7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/0c887a492733aab96ac405a5871f559a.cf.webp",
              "width": 1024,
              "height": 768,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/woUn3cfJYPXMhxA4_4CCeg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/0c887a492733aab96ac405a5871f559a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/equities-fall-intraday-tech-sector-190048469.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/equities-fall-intraday-tech-sector-190048469.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GC=F"
            },
            {
              "symbol": "SI=F"
            },
            {
              "symbol": "IBM"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "CRM"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "MSFT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T20:07:11+00:00",
    "headline": "Amgen Lawsuit Over 340B Discounts As Stock Trades Near Valuation Targets",
    "summary": "Amgen is being sued over an alleged unlawful decision to end discounted drug sales to Sagebrush Health Services under the federal 340B Drug Pricing Program. The lawsuit claims the move restricts access to lower cost medications for patients served by Sagebrush, which focuses on underserved communities. The case centers on Amgen's compliance with 340B rules that aim to reduce drug costs for vulnerable patient groups. For investors watching NasdaqGS:AMGN, this legal dispute arrives with the...",
    "url": "https://finance.yahoo.com/news/amgen-lawsuit-over-340b-discounts-200711867.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "359257c3-4d16-356c-a6a9-2d716c75a89f",
      "content": {
        "id": "359257c3-4d16-356c-a6a9-2d716c75a89f",
        "contentType": "STORY",
        "title": "Amgen Lawsuit Over 340B Discounts As Stock Trades Near Valuation Targets",
        "description": "",
        "summary": "Amgen is being sued over an alleged unlawful decision to end discounted drug sales to Sagebrush Health Services under the federal 340B Drug Pricing Program. The lawsuit claims the move restricts access to lower cost medications for patients served by Sagebrush, which focuses on underserved communities. The case centers on Amgen's compliance with 340B rules that aim to reduce drug costs for vulnerable patient groups. For investors watching NasdaqGS:AMGN, this legal dispute arrives with the...",
        "pubDate": "2026-02-03T20:07:11Z",
        "displayTime": "2026-02-03T20:07:11Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ACuIXYrNeojUXbAJFhnPIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/B7CQJIEa.2c0sQ0XIU66pg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-lawsuit-over-340b-discounts-200711867.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-lawsuit-over-340b-discounts-200711867.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T21:54:51+00:00",
    "headline": "Dow Jones Futures: Nasdaq Breaks Support As Walmart Hits Milestone; AMD, Lumentum Are Earnings Movers Late",
    "summary": "Techs and chips struggled Tuesday, while consumer staples, regional banks, precious metals and industrials are areas of strength. AMD, Lumentum were earnings movers late.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-nasdaq-breaks-support-walmart-milestone-amd-earnings/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "23eeeff1-131b-398b-8891-040dddfd32b1",
      "content": {
        "id": "23eeeff1-131b-398b-8891-040dddfd32b1",
        "contentType": "STORY",
        "title": "Dow Jones Futures: Nasdaq Breaks Support As Walmart Hits Milestone; AMD, Lumentum Are Earnings Movers Late",
        "description": "",
        "summary": "Techs and chips struggled Tuesday, while consumer staples, regional banks, precious metals and industrials are areas of strength. AMD, Lumentum were earnings movers late.",
        "pubDate": "2026-02-03T21:54:51Z",
        "displayTime": "2026-02-03T21:54:51Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/23eeeff1-131b-398b-8891-040dddfd32b1/dow-jones-futures-nasdaq.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/97200b9fafefda1e2cf6a68b0fa17b19",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aHrEFhoozM_y8Uscggjmjg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/97200b9fafefda1e2cf6a68b0fa17b19.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l19Lb4M6_IQ.52HFT1YZWQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/97200b9fafefda1e2cf6a68b0fa17b19.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-nasdaq-breaks-support-walmart-milestone-amd-earnings/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "LITE"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "WMT"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "HALO"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "PEP"
            },
            {
              "symbol": "EXPE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T21:41:40+00:00",
    "headline": "Amgen beats Q4 expectations with 9% revenue growth, issues strong 2026 guidance",
    "summary": "Investing.com -- Amgen (NASDAQ:AMGN) reported fourth-quarter earnings that exceeded analyst expectations, with revenue climbing 9% to $9.9 billion compared to the consensus estimate of $9.46 billion. Shares were up 1.3% in after hours trading Tuesday following the announcement.",
    "url": "https://finance.yahoo.com/news/amgen-beats-q4-expectations-9-214140095.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "eb86e4ad-4735-3c00-9dfd-3a0e650d9975",
      "content": {
        "id": "eb86e4ad-4735-3c00-9dfd-3a0e650d9975",
        "contentType": "STORY",
        "title": "Amgen beats Q4 expectations with 9% revenue growth, issues strong 2026 guidance",
        "description": "",
        "summary": "Investing.com -- Amgen (NASDAQ:AMGN) reported fourth-quarter earnings that exceeded analyst expectations, with revenue climbing 9% to $9.9 billion compared to the consensus estimate of $9.46 billion. Shares were up 1.3% in after hours trading Tuesday following the announcement.",
        "pubDate": "2026-02-03T21:41:40Z",
        "displayTime": "2026-02-03T21:41:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-beats-q4-expectations-9-214140095.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-beats-q4-expectations-9-214140095.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T21:19:20+00:00",
    "headline": "Amgen Jumps Back Into A Buy Zone After Strong Fourth-Quarter Report",
    "summary": "Amgen stock rose late Tuesday on better-than-expected fourth-quarter sales and adjusted earnings per share.",
    "url": "https://www.investors.com/news/technology/amgen-stock-amgen-earnings-q4-2025/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "e8b9f536-520f-3da4-b546-112d47f2cb10",
      "content": {
        "id": "e8b9f536-520f-3da4-b546-112d47f2cb10",
        "contentType": "STORY",
        "title": "Amgen Jumps Back Into A Buy Zone After Strong Fourth-Quarter Report",
        "description": "",
        "summary": "Amgen stock rose late Tuesday on better-than-expected fourth-quarter sales and adjusted earnings per share.",
        "pubDate": "2026-02-03T21:19:20Z",
        "displayTime": "2026-02-03T21:19:20Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e8b9f536-520f-3da4-b546-112d47f2cb10/amgen-jumps-back-into-a-buy.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/7ba14abd9df9395abbc23807754359d5",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BdP_5hz8dXtP45ZN_yRcwQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/7ba14abd9df9395abbc23807754359d5.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3NvDj.DvedgTM3JJ8NWMVg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/7ba14abd9df9395abbc23807754359d5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/amgen-stock-amgen-earnings-q4-2025/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T21:13:30+00:00",
    "headline": "Amgen (NASDAQ:AMGN) Reports Upbeat Q4 CY2025",
    "summary": "Biotech company Amgen (NASDAQ:AMGN) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 8.6% year on year to $9.87 billion. The company’s full-year revenue guidance of $37.7 billion at the midpoint came in 1.8% above analysts’ estimates. Its non-GAAP profit of $5.29 per share was 11.9% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/amgen-nasdaq-amgn-reports-upbeat-211330527.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "c2e39cdd-c9e7-36f5-9e09-917fefcdada9",
      "content": {
        "id": "c2e39cdd-c9e7-36f5-9e09-917fefcdada9",
        "contentType": "STORY",
        "title": "Amgen (NASDAQ:AMGN) Reports Upbeat Q4 CY2025",
        "description": "",
        "summary": "Biotech company Amgen (NASDAQ:AMGN) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 8.6% year on year to $9.87 billion. The company’s full-year revenue guidance of $37.7 billion at the midpoint came in 1.8% above analysts’ estimates. Its non-GAAP profit of $5.29 per share was 11.9% above analysts’ consensus estimates.",
        "pubDate": "2026-02-03T21:13:30Z",
        "displayTime": "2026-02-03T21:13:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/85fc5540fd7647d2927a8cba48ff7e92",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "AMGN Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cVRDvNeMN6SVWgnyfhcabA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/85fc5540fd7647d2927a8cba48ff7e92.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/khfuGqTIKrJ0BdS6OOusRA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/85fc5540fd7647d2927a8cba48ff7e92.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-nasdaq-amgn-reports-upbeat-211330527.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-nasdaq-amgn-reports-upbeat-211330527.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T21:07:17+00:00",
    "headline": "Amgen: Q4 Earnings Snapshot",
    "summary": "AMGN) on Tuesday reported fourth-quarter profit of $1.33 billion. On a per-share basis, the Thousand Oaks, California-based company said it had profit of $2.45. Earnings, adjusted for non-recurring costs, were $5.29 per share.",
    "url": "https://finance.yahoo.com/news/amgen-q4-earnings-snapshot-210717128.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "f67026c4-7e04-3b28-908e-5292da3f0b28",
      "content": {
        "id": "f67026c4-7e04-3b28-908e-5292da3f0b28",
        "contentType": "STORY",
        "title": "Amgen: Q4 Earnings Snapshot",
        "description": "",
        "summary": "AMGN) on Tuesday reported fourth-quarter profit of $1.33 billion. On a per-share basis, the Thousand Oaks, California-based company said it had profit of $2.45. Earnings, adjusted for non-recurring costs, were $5.29 per share.",
        "pubDate": "2026-02-03T21:07:17Z",
        "displayTime": "2026-02-03T21:07:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-q4-earnings-snapshot-210717128.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-q4-earnings-snapshot-210717128.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T21:04:55+00:00",
    "headline": "Amgen quarterly results beat Street estimates on higher sales, lower tax rate",
    "summary": "Feb 3 () - Amgen on Tuesday reported fourth-quarter financial results that came in ahead of Wall Street expectations, driven by a 7% ​increase in drug sales and a lower tax rate. The California-based biotech company's ‌overall quarterly revenue rose 9% from a year earlier to $9.",
    "url": "https://finance.yahoo.com/news/amgen-quarterly-results-beat-street-210455254.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "ff3e7a63-00ec-3186-8f85-e820c4c2e6c8",
      "content": {
        "id": "ff3e7a63-00ec-3186-8f85-e820c4c2e6c8",
        "contentType": "STORY",
        "title": "Amgen quarterly results beat Street estimates on higher sales, lower tax rate",
        "description": "",
        "summary": "Feb 3 () - Amgen on Tuesday reported fourth-quarter financial results that came in ahead of Wall Street expectations, driven by a 7% ​increase in drug sales and a lower tax rate. The California-based biotech company's ‌overall quarterly revenue rose 9% from a year earlier to $9.",
        "pubDate": "2026-02-03T21:04:55Z",
        "displayTime": "2026-02-03T21:04:55Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/83393e14e8fdccae2828e8aaf6a9686e",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "FILE PHOTO: The Amgen logo is seen in this illustration taken August 3, 2025. REUTERS/Dado Ruvic/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/W2LopJX.WWD2aUCY1rCXmg--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/83393e14e8fdccae2828e8aaf6a9686e.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yH1K4kiqYzRGgr8skIP_Tg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/83393e14e8fdccae2828e8aaf6a9686e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-quarterly-results-beat-street-210455254.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-quarterly-results-beat-street-210455254.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T21:01:00+00:00",
    "headline": "AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS",
    "summary": "Amgen (NASDAQ: AMGN) today announced financial results for the fourth quarter and full year of 2025 versus the comparable periods in 2024.",
    "url": "https://finance.yahoo.com/news/amgen-reports-fourth-quarter-full-210100986.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "97ca8284-f0d6-317c-8797-7b8e1ccadbc0",
      "content": {
        "id": "97ca8284-f0d6-317c-8797-7b8e1ccadbc0",
        "contentType": "STORY",
        "title": "AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS",
        "description": "",
        "summary": "Amgen (NASDAQ: AMGN) today announced financial results for the fourth quarter and full year of 2025 versus the comparable periods in 2024.",
        "pubDate": "2026-02-03T21:01:00Z",
        "displayTime": "2026-02-03T21:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/dd88fc63427022d71ca8183432abc09d",
          "originalWidth": 400,
          "originalHeight": 98,
          "caption": "Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9xF64eSNrBTdXVSUBRIisA--~B/aD05ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/dd88fc63427022d71ca8183432abc09d.cf.webp",
              "width": 400,
              "height": 98,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LmrL8PQB2Q2cD.YsureBSw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/dd88fc63427022d71ca8183432abc09d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-reports-fourth-quarter-full-210100986.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-reports-fourth-quarter-full-210100986.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T23:22:49+00:00",
    "headline": "Dow Jones Futures: Nasdaq Tumbles But These Sectors Lead; AMD, Lumentum Are Earnings Movers Late",
    "summary": "Techs and chips struggled Tuesday, while consumer staples, regional banks, precious metals and industrials are areas of strength. AMD, Lumentum were earnings movers late.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-nasdaq-breaks-support-walmart-milestone-amd-earnings/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "23eeeff1-131b-398b-8891-040dddfd32b1",
      "content": {
        "id": "23eeeff1-131b-398b-8891-040dddfd32b1",
        "contentType": "STORY",
        "title": "Dow Jones Futures: Nasdaq Tumbles But These Sectors Lead; AMD, Lumentum Are Earnings Movers Late",
        "description": "",
        "summary": "Techs and chips struggled Tuesday, while consumer staples, regional banks, precious metals and industrials are areas of strength. AMD, Lumentum were earnings movers late.",
        "pubDate": "2026-02-03T23:22:49Z",
        "displayTime": "2026-02-03T23:22:49Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/23eeeff1-131b-398b-8891-040dddfd32b1/dow-jones-futures-nasdaq.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/97200b9fafefda1e2cf6a68b0fa17b19",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aHrEFhoozM_y8Uscggjmjg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/97200b9fafefda1e2cf6a68b0fa17b19.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l19Lb4M6_IQ.52HFT1YZWQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/97200b9fafefda1e2cf6a68b0fa17b19.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-nasdaq-breaks-support-walmart-milestone-amd-earnings/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "LITE"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PEP"
            },
            {
              "symbol": "WMT"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "HALO"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "EXPE"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T23:10:59+00:00",
    "headline": "Amgen (AMGN) Q4 2025 Earnings Call Transcript",
    "summary": "Amgen Inc. delivered strong operational performance across the board in 2025, and you can see that in the breadth of our business.  Three of these, Repatha, Evenity, and TestSpire, all grew by more than 30% year over year in 2025.",
    "url": "https://www.fool.com/earnings/call-transcripts/2026/02/03/amgen-amgn-q4-2025-earnings-call-transcript/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "54b19066-8215-33be-801f-f4eb951f88fb",
      "content": {
        "id": "54b19066-8215-33be-801f-f4eb951f88fb",
        "contentType": "STORY",
        "title": "Amgen (AMGN) Q4 2025 Earnings Call Transcript",
        "description": "",
        "summary": "Amgen Inc. delivered strong operational performance across the board in 2025, and you can see that in the breadth of our business.  Three of these, Repatha, Evenity, and TestSpire, all grew by more than 30% year over year in 2025.",
        "pubDate": "2026-02-03T23:10:59Z",
        "displayTime": "2026-02-03T23:10:59Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73",
          "originalWidth": 400,
          "originalHeight": 427,
          "caption": "Logo of jester cap with thought bubble.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/V1aMxfEJkXDsPjicitZiIw--~B/aD00Mjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73.cf.webp",
              "width": 400,
              "height": 427,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XzH.opsl71yJif6AsJGwPw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/earnings/call-transcripts/2026/02/03/amgen-amgn-q4-2025-earnings-call-transcript/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-amgn-q4-2025-earnings-231059460.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T23:07:49+00:00",
    "headline": "Amgen Q4 Earnings Call Highlights",
    "summary": "Amgen (NASDAQ:AMGN) executives highlighted broad-based growth in 2025 and laid out expectations for continued momentum in 2026, while also detailing pipeline priorities, portfolio decisions, and a regulatory dialogue related to Tavneos during the company’s fourth-quarter earnings call. 2025 results",
    "url": "https://www.marketbeat.com/instant-alerts/amgen-q4-earnings-call-highlights-2026-02-03/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "dfb57cc1-5716-3fc5-a9fe-c5b0d75f7647",
      "content": {
        "id": "dfb57cc1-5716-3fc5-a9fe-c5b0d75f7647",
        "contentType": "STORY",
        "title": "Amgen Q4 Earnings Call Highlights",
        "description": "",
        "summary": "Amgen (NASDAQ:AMGN) executives highlighted broad-based growth in 2025 and laid out expectations for continued momentum in 2026, while also detailing pipeline priorities, portfolio decisions, and a regulatory dialogue related to Tavneos during the company’s fourth-quarter earnings call. 2025 results",
        "pubDate": "2026-02-03T23:07:49Z",
        "displayTime": "2026-02-03T23:07:49Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/4909f551de818c56e42d3c9ab5f5456b",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Amgen logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/du5DeAl0vfsu8qD9DGoJyw--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/4909f551de818c56e42d3c9ab5f5456b.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GeOU9jSAhtvzM5tx5QWlcw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/4909f551de818c56e42d3c9ab5f5456b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/instant-alerts/amgen-q4-earnings-call-highlights-2026-02-03/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-q4-earnings-call-highlights-230749561.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T22:07:06+00:00",
    "headline": "Amgen Eyes Buy Zone After Fourth-Quarter Beat As Obesity Studies Mount",
    "summary": "Amgen stock popped late Tuesday — and could retake its buy zone — after the biotech behemoth easily topped fourth-quarter expectations on the back of big sales beats from cholesterol drug Repatha and osteoporosis treatment Prolia.  The company also reaffirmed its bullish plans for obesity treatment MariTide.  In after-hours trades on today's stock market, Amgen stock rose more than 1% to 343.",
    "url": "https://www.investors.com/news/technology/amgen-stock-amgen-earnings-q4-2025/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "e8b9f536-520f-3da4-b546-112d47f2cb10",
      "content": {
        "id": "e8b9f536-520f-3da4-b546-112d47f2cb10",
        "contentType": "STORY",
        "title": "Amgen Eyes Buy Zone After Fourth-Quarter Beat As Obesity Studies Mount",
        "description": "",
        "summary": "Amgen stock popped late Tuesday — and could retake its buy zone — after the biotech behemoth easily topped fourth-quarter expectations on the back of big sales beats from cholesterol drug Repatha and osteoporosis treatment Prolia.  The company also reaffirmed its bullish plans for obesity treatment MariTide.  In after-hours trades on today's stock market, Amgen stock rose more than 1% to 343.",
        "pubDate": "2026-02-03T22:07:06Z",
        "displayTime": "2026-02-03T22:07:06Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e8b9f536-520f-3da4-b546-112d47f2cb10/amgen-eyes-buy-zone-after.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/7ba14abd9df9395abbc23807754359d5",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BdP_5hz8dXtP45ZN_yRcwQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/7ba14abd9df9395abbc23807754359d5.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3NvDj.DvedgTM3JJ8NWMVg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/7ba14abd9df9395abbc23807754359d5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/amgen-stock-amgen-earnings-q4-2025/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T21:58:00+00:00",
    "headline": "Amgen’s Revenue Climbs on Double-Digit Volume Boost",
    "summary": "The biotech company’s results follow the launch of its direct-to-patient program designed to lower the cost of drugs.",
    "url": "https://www.wsj.com/business/earnings/amgen-logs-higher-fourth-quarter-revenue-on-double-digit-volume-boost-918dec13?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "a3e78bed-636e-3366-9cbe-8ec0fc755cb1",
      "content": {
        "id": "a3e78bed-636e-3366-9cbe-8ec0fc755cb1",
        "contentType": "STORY",
        "title": "Amgen’s Revenue Climbs on Double-Digit Volume Boost",
        "description": "",
        "summary": "The biotech company’s results follow the launch of its direct-to-patient program designed to lower the cost of drugs.",
        "pubDate": "2026-02-03T21:58:00Z",
        "displayTime": "2026-02-03T21:58:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/a3e78bed-636e-3366-9cbe-8ec0fc755cb1/amgen%E2%80%99s-revenue-climbs-on.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/9bb6be71893adebfbdfc09123fb75a49",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7gzRFCtdw3HK14_9bSvF1Q--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/9bb6be71893adebfbdfc09123fb75a49.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/USnvZyCIYoIc32docX_ISQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/9bb6be71893adebfbdfc09123fb75a49.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/business/earnings/amgen-logs-higher-fourth-quarter-revenue-on-double-digit-volume-boost-918dec13?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "FDS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T23:00:02+00:00",
    "headline": "Here's What Key Metrics Tell Us About Amgen (AMGN) Q4 Earnings",
    "summary": "Although the revenue and EPS for Amgen (AMGN) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
    "url": "https://finance.yahoo.com/news/heres-key-metrics-tell-us-230002865.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "c1b28632-5899-3113-a79e-ed28ae2b9aab",
      "content": {
        "id": "c1b28632-5899-3113-a79e-ed28ae2b9aab",
        "contentType": "STORY",
        "title": "Here's What Key Metrics Tell Us About Amgen (AMGN) Q4 Earnings",
        "description": "",
        "summary": "Although the revenue and EPS for Amgen (AMGN) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
        "pubDate": "2026-02-03T23:00:02Z",
        "displayTime": "2026-02-03T23:00:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/98CLu2lmSTUpr4OkMLeHwg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qpn93q_5cIRTjhBkSx0KNQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-key-metrics-tell-us-230002865.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-key-metrics-tell-us-230002865.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T22:10:01+00:00",
    "headline": "Amgen (AMGN) Q4 Earnings and Revenues Beat Estimates",
    "summary": "Amgen (AMGN) delivered earnings and revenue surprises of +11.18% and +4.23%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finance.yahoo.com/news/amgen-amgn-q4-earnings-revenues-221001471.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "954b5c89-6d73-3ac9-b45e-8b08a4b437c7",
      "content": {
        "id": "954b5c89-6d73-3ac9-b45e-8b08a4b437c7",
        "contentType": "STORY",
        "title": "Amgen (AMGN) Q4 Earnings and Revenues Beat Estimates",
        "description": "",
        "summary": "Amgen (AMGN) delivered earnings and revenue surprises of +11.18% and +4.23%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
        "pubDate": "2026-02-03T22:10:01Z",
        "displayTime": "2026-02-03T22:10:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/21b1f011539d3e31c28282071d344177",
          "originalWidth": 900,
          "originalHeight": 598,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2yFNHFE.NEelN3EcxccP6Q--~B/aD01OTg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/21b1f011539d3e31c28282071d344177.cf.webp",
              "width": 900,
              "height": 598,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tL0vRMsfrFLR6L27GP3atA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/21b1f011539d3e31c28282071d344177.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-amgn-q4-earnings-revenues-221001471.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-amgn-q4-earnings-revenues-221001471.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T21:41:40+00:00",
    "headline": "Amgen beats expectations, issues strong 2026 guidance; shares rise premarket",
    "summary": "Investing.com -- Amgen reported fourth-quarter earnings that exceeded analyst expectations, with revenue climbing 9% to $9.9 billion compared to the consensus estimate of $9.46 billion.",
    "url": "https://finance.yahoo.com/news/amgen-beats-q4-expectations-9-214140095.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "eb86e4ad-4735-3c00-9dfd-3a0e650d9975",
      "content": {
        "id": "eb86e4ad-4735-3c00-9dfd-3a0e650d9975",
        "contentType": "STORY",
        "title": "Amgen beats expectations, issues strong 2026 guidance; shares rise premarket",
        "description": "",
        "summary": "Investing.com -- Amgen reported fourth-quarter earnings that exceeded analyst expectations, with revenue climbing 9% to $9.9 billion compared to the consensus estimate of $9.46 billion.",
        "pubDate": "2026-02-03T21:41:40Z",
        "displayTime": "2026-02-03T21:41:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-beats-q4-expectations-9-214140095.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-beats-q4-expectations-9-214140095.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]